News
Alembic Pharmaceuticals' Karakhadi unit completes USFDA inspection
14-May-2026 | 15:23
Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) from the USFDA, for its Injectable facility (F-III) located at Karakhadi on 13 May 2026. The USFDA inspection was conducted from 9 February 2026 to 18 February 2026.
